The Molecular Anatomy of Oral Wound Healing
2 other identifiers
observational
53
1 country
1
Brief Summary
Background:
- Two important properties distinguish the healing process of skin wounds from that of wounds of the mucous membranes of the mouth (oral mucosa). Although the skin and the oral mucosa tissues are similar in nature, oral mucosa have more rapid healing and a lack of scar tissue formation. However, oral wound healing in general has been poorly studied, and more information is needed to determine how specific aspects of the oral environment affect the healing process.
- Researchers are interested in identifying various factors that contribute to oral wound healing. Studying this process would help researchers explore procedures to accelerate the healing of critically-sized oral lesions formed by trauma, surgery, radiation therapy, infection, and other damage to the mouth. In addition, research into scar-free healing could be applied to other mucosal sites to promote healing and minimize unsightly scars that may compromise the tissue. Objectives: \- To identify the specific factors that enable rapid and nearly scar-free healing of oral mucosa. Eligibility:
- Healthy male volunteers between 18 and 40 years of age.
- Regular cigarette, cigar, and pipe smokers; occasional smokers who smoke more than 1 day a week or have smoked in the prior month; users of chewing tobacco or betel nut; and heavy drinkers (three or more alcoholic drinks per day) will be excluded. Design:
- Participants will have a medical history and examination, and will provide blood samples at the start of the study.
- Participants will provide oral mucosa samples from the inside of the cheek, taken using a dermal punch. At the same time, participants will provide skin biopsy samples of approximately the same size. After the skin and oral mucosa samples are taken, participants will be divided into three groups for follow-up procedures.
- Group 1: No further samples will be collected. This group will help document the normal healing process.
- Group 2: A second, slightly larger biopsy, which will include the area of the first biopsy, will be taken on day 3. Both skin and oral mucosa biopsies will be taken.
- Group 3: A second, slightly larger biopsy will be taken on day 6, in a similar way as described for Group 2. Both skin and oral mucosa biopsies will be taken.
- Wounds will be photographed with a digital camera on days 3, 6, 9, 13, and 15; and the healing will be monitored at the scheduled clinic visits.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2010
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 2, 2010
CompletedFirst Submitted
Initial submission to the registry
February 27, 2010
CompletedFirst Posted
Study publicly available on registry
March 2, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
February 19, 2019
CompletedDecember 3, 2019
February 19, 2019
February 27, 2010
November 30, 2019
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- Healthy male volunteers age 18 to 40.
- All volunteers must sign informed consent indicating their understanding that specimens and demographic information will be collected solely for research purposes.
You may not qualify if:
- Subjects with known inflammatory, chronic, and infectious diseases. These conditions include but are not limited to:
- Diabetes
- Heart failure
- Pulmonary disease
- Rheumatoid arthritis
- Systemic lupus erythematosus
- Sarcoidosis
- Sj(SqrRoot)(Delta)grens syndrome
- Dermatomyositis
- Psoriasis
- Cellulitis
- Patients with known bleeding disorders or conditions associated with bleeding. These conditions include but are not limited to:
- Hemophilia
- von Willebrand disease
- Protein C/S deficiency
- +31 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, 20892, United States
Related Publications (3)
Schafer M, Werner S. Transcriptional control of wound repair. Annu Rev Cell Dev Biol. 2007;23:69-92. doi: 10.1146/annurev.cellbio.23.090506.123609.
PMID: 17474876BACKGROUNDBaker H, Patel V, Molinolo AA, Shillitoe EJ, Ensley JF, Yoo GH, Meneses-Garcia A, Myers JN, El-Naggar AK, Gutkind JS, Hancock WS. Proteome-wide analysis of head and neck squamous cell carcinomas using laser-capture microdissection and tandem mass spectrometry. Oral Oncol. 2005 Feb;41(2):183-99. doi: 10.1016/j.oraloncology.2004.08.009.
PMID: 15695121BACKGROUNDLee HG, Eun HC. Differences between fibroblasts cultured from oral mucosa and normal skin: implication to wound healing. J Dermatol Sci. 1999 Nov;21(3):176-82. doi: 10.1016/s0923-1811(99)00037-7.
PMID: 10527379BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Janice S Lee, DDS, MD
National Institute of Dental and Craniofacial Research (NIDCR)
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 27, 2010
First Posted
March 2, 2010
Study Start
February 2, 2010
Study Completion
February 19, 2019
Last Updated
December 3, 2019
Record last verified: 2019-02-19